- Summer of 2023 Was Hottest in 2,000 Years
- San Francisco Set to Ban ‘Forever Chemicals’ in Firefighter Gear
- More Studies Support Wegovy’s Long-Term Weight-Loss Benefits
- Americans With Private Insurance May Pay More for Hospital Stay
- Patients Over 80 Still Benefit From Treatment for AML Blood Cancer
- Why C-Section Babies Need 2 Doses of Measles Vaccine
- Vaping Rates Fall Among Teens, But Still Too High
- Science Shows How Night Shifts Help Bring on Disease
- Melanoma Can Strike Black Americans, Often With Deadlier Results
- Smoking During Pregnancy Could Raise Baby’s Odds for Obesity Later
New Tests May Help Combat Melanoma, Expert Says
Genetic and molecular tests can be valuable in helping to diagnose and treat deadly melanoma skin cancer, a dermatologist says.
The tests are widely available in the United States, and many are covered by insurance or offered at no extra cost, said Dr. Emily Chu. She is an assistant professor of dermatology and pathology and laboratory medicine at the University of Pennsylvania, in Philadelphia.
Melanoma rates in the United States have doubled over the past three decades, according to the U.S. Centers for Disease Control and Prevention. Tissue biopsy is typically used to diagnose skin cancer, but biopsy results aren’t always definitive. In such cases, genetic and molecular tests can help determine if a patient has skin cancer, Chu said.
She added that such tests may also help identify the most effective treatments for patients with advanced melanoma.
Continuing research into specific melanoma mutations and targeted treatments could lead to more effective therapies in the future, the researcher said.
“Although genetic and molecular testing for melanoma has advanced in recent years, it’s still an emerging field. I think it will only get better,” Chu said in an American Academy of Dermatology news release timed to coincide with the academy’s annual meeting, which begins Friday in Washington, D.C.
While genetic and molecular tests are helpful, Chu explained that their results have to be considered along with other information.
“Genetic and molecular tests are a valuable tool in our arsenal for fighting melanoma,” Chu said. “When used appropriately, these tests can provide dermatologists with important information to assist them in melanoma diagnosis and treatment, allowing them to provide patients with the best possible care.”
More information
The U.S. National Cancer Institute has more on melanoma.
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.